1. |
Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 2012, 150(6): 1107-1120.
|
2. |
方三高, 陈真伟, 魏建国. 2021年第5版WHO胸部肿瘤分类. 诊断病理学杂志, 2021, 28(7): 591-593, 607.
|
3. |
Li Q, Dai J, Zhang P, et al. Management of pulmonary ground glass nodules: Less is more. Ann Thorac Surg, 2021, 112(1): 1-2.
|
4. |
郑慧, 李建玉, 王珊, 等. 基于肺磨玻璃结节CT征象的诊断模型列线图评估肺癌浸润性. 放射学实践, 2021, 36(4): 470-474.
|
5. |
Godoy MC, Sabloff B, Naidich DP. Subsolid pulmonary nodules: Imaging evaluation and strategic management. Curr Opin Pulm Med, 2012, 18(4): 304-312.
|
6. |
Seidelman JL, Myers JL, Quint LE. Incidental, subsolid pulmonary nodules at CT: Etiology and management. Cancer Imaging, 2013, 13(3): 365-373.
|
7. |
孟庆成, 贾丙鑫, 张建伟, 等. 微浸润型肺腺癌的高分辨率CT表现. 中国医学影像学杂志, 2013, 21(7): 536-538, 542.
|
8. |
刘佳, 李文武, 黄勇, 等. 表现为磨玻璃密度结节的肺腺癌浸润前病变与微浸润腺癌的多排螺旋CT影像学征象及其鉴别诊断价值. 中华肿瘤杂志, 2015, 37(8): 611-616.
|
9. |
Syrigos K, Fiste O, Charpidou A, et al. Circulating tumor cells count as a predictor of survival in lung cancer. Crit Rev Oncol Hematol, 2018, 125: 60-68.
|
10. |
Wang J, Wang K, Xu J, et al. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: A meta-analysis. PLoS One, 2013, 8(11): e78070.
|
11. |
Gao Y, Ni X, Guo H, et al. Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells. Genome Res, 2017, 27(8): 1312-1322.
|
12. |
Yin W, Zhu J, Ma B, et al. Overcoming obstacles in pathological diagnosis of pulmonary nodules through circulating tumor cell enrichment. Small, 2020, 16(25): e2001695.
|
13. |
Wilshire CL, Louie BE, Horton MP, et al. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience. J Thorac Cardiovasc Surg, 2016, 151(6): 1561-1568.
|
14. |
何花, 胡文滕, 蔺瑞江, 等. CT特征联合肿瘤标志物预测肺磨玻璃结节肿瘤浸润性的回顾性队列研究. 中国胸心血管外科临床杂志, 2022, 29(9): 1113-1119.
|
15. |
Zhai Y, Hui Z, Men Y, et al. Combined neat model for the prognosis of postoperative stage Ⅲ-N2 non-small cell lung cancer. Thorac Cancer, 2020, 11(9): 2610-2617.
|
16. |
Yoshimura A, Uchino J, Hasegawa K, et al. Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer. Transl Lung Cancer Res, 2019, 8(3): 227-234.
|
17. |
Tomita M, Ayabe T, Maeda R, et al. Serum carcinoembryonic antigen level predicts cancer-specific outcomes of resected non-small cell lung cancer with interstitial pneumonia. World J Oncol, 2018, 9(5-6): 136-140.
|
18. |
陈耿春, 李阳, 邱士军. 肺部小结节与浸润性肺癌的影像学相关性研究. 现代诊断与治疗, 2018, 29(24): 4010-4012.
|
19. |
单文莉, 周围, 孔丹, 等. 肺腺癌CT征象与病理组织学亚型及分化程度的对照研究. 临床放射学杂志, 2019, 38(12): 2312-2316.
|
20. |
黄海峡, 徐国厚, 左翔, 等. CT特征联合癌胚抗原对磨玻璃结节的浸润前和浸润性鉴别诊断价值的研究. 中国CT和MRI杂志, 2020, 18(10): 29-33.
|
21. |
Miao Y, Zhang J, Zou J, et al. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma. Transl Lung Cancer Res, 2017, 6(1): 14-22.
|